
Dxcover is a clinical-stage company focused on revolutionizing cancer diagnostics with its multi-omic platform powered by light and machine learning. The company aims to enable earlier detection of multiple cancers, initially focusing on brain tumors, to improve patient survival and quality of life. Their PANAROMIC™ platform utilizes infrared spectroscopy of circulating pan-omic biomarkers for early cancer detection. Dxcover has generated significant clinical data, demonstrating high accuracy in detecting early-stage cancers, and has a mission to democratize cancer care globally.

Dxcover is a clinical-stage company focused on revolutionizing cancer diagnostics with its multi-omic platform powered by light and machine learning. The company aims to enable earlier detection of multiple cancers, initially focusing on brain tumors, to improve patient survival and quality of life. Their PANAROMIC™ platform utilizes infrared spectroscopy of circulating pan-omic biomarkers for early cancer detection. Dxcover has generated significant clinical data, demonstrating high accuracy in detecting early-stage cancers, and has a mission to democratize cancer care globally.